3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Hematologic Neoplasms
1
Graft vs Host Disease
1
Interventions
Cytarabine
83
Methotrexate
59
Cyclophosphamide
58
Vincristine
47
Daunorubicin
46
Prednisone
33
Mercaptopurine
33
Asparaginase
33
Dexamethasone
31
Doxorubicin
29
Gene Expression Profiling
27
Etoposide
27
pegaspargase
25
Radiotherapy
25
Filgrastim
25
Thioguanine
24
Leucovorin
24
Flow Cytometry
23
merphos
22
Hydrocortisone
20
Calcium Dobesilate
20
Specimen Handling
18
Microarray Analysis
16
Idarubicin
16
Granulocyte Colony-Stimulating Factor
15
Peripheral Blood Stem Cell Transplantation
14
Busulfan
14
Polymerase Chain Reaction
13
Mitoxantrone
13
Gemtuzumab
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
trihexyltetradecylphosphonium chloride
×
Other hematologic neoplasm
×
Clear all
NCT05158608
2022-01-11
CY25
National Research Center for Hematology, Russia
Phase 3
Unknown
100 enrolled